Literature DB >> 26276293

Influence of overexpression of SOCS2 on cells of DN rat.

Na-Na Bao1, De-Yang Kong1, Dan Zhu1, Li-Rong Hao2.   

Abstract

OBJECTIVE: To explore the influence and mechanism of overexpression of SOCS2 on diabetic nephropathy (DN) rats and cells.
METHODS: STZ was used to induce male SD rats and SOCS2 was injected into left renal vein. Rats were divided into DN group, DN-Ad-null group and DN-Ad-SOCS2 group. Glucose with high and normal concentration was used to culture HBZY-1 cells and then transfect Ad-SOCS2. HG group, HG-Ad-null group, HG-Ad-SOCS2 group, CG group, CG-Ad-null group, and CG-Ad-SOCS2 group were created. The expression of inflammatory cytokines (MCP-1, TNF-α and IL-6) in kidney tissue of rats, fibrosis related protein (FN, Collagen IV and TGF-β) in kidney tissue and cells of rats, and JAK/STAT signaling pathway related proteins (p-JAK2 and p-STAT3) were tested by western blot. ELISA was used to test the expression of inflammatory cytokines (TNF-α and IL-6) in cells.
RESULTS: The expression of inflammatory cytokines in DN rats (MCP-1, TNF-α and IL-6) and cell (TNF-α and IL-6) were increased (P < 0.01) significantly. However, SOCS2 could decrease the overexpression of mediated inflammatory cytokines in DN animal models and cell models (P < 0.01). The expression of fibrosis related protein in DN rats and cells increased while SOCS2 decreased the overexpression of mediated fibrosis related protein in DN model rats and cells (P < 0.01). The expression of JAK/STAT pathway related protein in both DN rats and cells increased and the JAK/STAT signaling pathway was activated. Yet, SOCS2 obviously suppressed the expression of the JAK/STAT signaling pathway as well as the related proteins (p-JAK2 and p-STAT3) in both DN rats and cells.
CONCLUSIONS: The overexpression of SOCS2 can decrease the expression of inflammatory cytokines and fibrosis related proteins in DN rats and cells, and meanwhile suppress the activation of JAK/STAT signaling pathway mediated by DN.
Copyright © 2015 Hainan Medical College. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine signaling; Diabetic nephropathy; JAK/STAT signaling pathway; Suppressor

Year:  2015        PMID: 26276293     DOI: 10.1016/j.apjtm.2015.06.006

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  4 in total

1.  SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-κB pathway.

Authors:  Suxia Yang; Junwei Zhang; Shiying Wang; Xinxin Zhao; Jun Shi
Journal:  Oncotarget       Date:  2017-08-24

2.  Circulating Exosomal SOCS2-AS1 Acts as a Novel Biomarker in Predicting the Diagnosis of Coronary Artery Disease.

Authors:  Caihong Liang; Lulu Zhang; Xiaoqing Lian; Tiantian Zhu; Yuqing Zhang; Ning Gu
Journal:  Biomed Res Int       Date:  2020-04-09       Impact factor: 3.411

3.  The Effect of SOCS2 Polymorphisms on Type 2 Diabetes Mellitus Susceptibility and Diabetic Complications in the Chinese Han Population.

Authors:  Juan Pan; Rui Tong; Qing Deng; Yanni Tian; Ning Wang; Yanqi Peng; Sijia Fei; Wei Zhang; Jiaqi Cui; Chaoying Guo; Juanchuan Yao; Cui Wei; Jing Xu
Journal:  Pharmgenomics Pers Med       Date:  2022-01-29

Review 4.  Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review.

Authors:  Chen Junren; Xie Xiaofang; Zhang Huiqiong; Li Gangmin; Yin Yanpeng; Cao Xiaoyu; Gao Yuqing; Li Yanan; Zhang Yue; Peng Fu; Peng Cheng
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.